Management of erroneous subcutaneous injection of vincristine-Reference-Cited by-同舟云学术

Management of erroneous subcutaneous injection of vincristine

Published:2020-06-06 Issue:10 Volume:61 Page:2530-2532
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

de Goycoechea Diego¹^ORCID,Dewarrat Natacha¹^ORCID,Rothuizen Laura E.²,Matter Maurice³^ORCID,Nagy Monika¹,Locher Gisèle⁴,Spertini Olivier¹^ORCID,Blum Sabine¹^ORCID

Affiliation:

1. Service and Central Laboratory of Hematology, Centre Hospitalier Universitaire Vaudois and UNIL, Lausanne, Switzerland;

2. Service of Clinical Pharmacology, Centre Hospitalier Universitaire Vaudois and UNIL, Lausanne, Switzerland;

3. Service of Visceral Surgery, Centre Hospitalier Universitaire Vaudois and UNIL, Lausanne, Switzerland;

4. Centre coordonnée d’oncologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2020.1772471

Reference11 articles.

1. Management of the extravasation of anti-neoplastic agents

2. Extravasation emergencies: state-of-the-art management and progress in clinical research

3. Extravasation of systemic hemato-oncological therapies

4. Vesicant Extravasation Part I: Mechanisms, Pathogenesis, and Nursing Care to Reduce Risk

5. Hyaluronidase as an antidote to extravasation ofVinca alkaloids: Clinical results

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Delayed presentation of vincristine extravasation;Journal of Oncology Pharmacy Practice;2023-07-20

2. Vincristine must NEVER be prepared or administered in a syringe;Leukemia & Lymphoma;2020-12-22